REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $706,391 | -54.0% | 61,586 | +1.5% | 0.00% | -50.0% |
Q2 2023 | $1,534,950 | -22.6% | 60,646 | -1.5% | 0.00% | -20.0% |
Q1 2023 | $1,983,267 | +180197.0% | 61,573 | +3.4% | 0.01% | +66.7% |
Q4 2022 | $1,100 | -99.9% | 59,560 | +0.9% | 0.00% | -40.0% |
Q3 2022 | $1,594,000 | +17.9% | 59,044 | +21.7% | 0.01% | +66.7% |
Q3 2021 | $1,352,000 | +16.9% | 48,515 | +24.3% | 0.00% | 0.0% |
Q2 2021 | $1,157,000 | +51.8% | 39,027 | +43.1% | 0.00% | +50.0% |
Q1 2021 | $762,000 | +57.4% | 27,267 | +41.7% | 0.00% | 0.0% |
Q3 2020 | $484,000 | +26.0% | 19,244 | +22.3% | 0.00% | +100.0% |
Q2 2020 | $384,000 | -70.1% | 15,741 | -83.3% | 0.00% | -91.7% |
Q2 2016 | $1,283,000 | -30.8% | 94,308 | -11.3% | 0.01% | -33.3% |
Q1 2016 | $1,855,000 | -34.3% | 106,265 | +28.6% | 0.02% | -35.7% |
Q4 2015 | $2,822,000 | +36.5% | 82,610 | +18.9% | 0.03% | +27.3% |
Q3 2015 | $2,068,000 | +89.2% | 69,496 | +103.3% | 0.02% | +100.0% |
Q2 2015 | $1,093,000 | – | 34,181 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |